Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Eriosema psoraleoides
Arbuste légumineux d'Afrique de l'Est et de l'Ouest utilisé en médecine traditionnelle pour les conditions respiratoires et comme tonique.
Eriosema psoraleoides is a leguminous herb from East and West Africa, traditionally used as a respiratory tonic and cough remedy. Its primary active constituents include the isoflavonoid eriosemonin, along with flavonoids and tannins, which contribute to its expectorant and anti-inflammatory properties. Limited preclinical evidence supports its traditional use for respiratory conditions, but clinical data are lacking.
Eriosemonin and related flavonoids are thought to exert expectorant effects by stimulating bronchial mucus secretion and enhancing ciliary activity, possibly through activation of β2-adrenergic receptors or inhibition of phosphodiesterase. The tannins and flavonoids also inhibit cyclooxygenase (COX) and lipoxygenase pathways, reducing airway inflammation and edema. Additionally, these compounds may modulate cytokine release (e.g., TNF-α, IL-6) and scavenge reactive oxygen species, contributing to overall respiratory support.
Arbuste légumineux d'Afrique de l'Est et de l'Ouest utilisé en médecine traditionnelle pour les conditions respiratoires et comme tonique.
Eriosema psoraleoides is a leguminous herb from East and West Africa, traditionally used as a respiratory tonic and cough remedy. Its primary active constituents include the isoflavonoid eriosemonin, along with flavonoids and tannins, which contribute to its expectorant and anti-inflammatory properties. Limited preclinical evidence supports its traditional use for respiratory conditions, but clinical data are lacking.
Eriosemonin and related flavonoids are thought to exert expectorant effects by stimulating bronchial mucus secretion and enhancing ciliary activity, possibly through activation of β2-adrenergic receptors or inhibition of phosphodiesterase. The tannins and flavonoids also inhibit cyclooxygenase (COX) and lipoxygenase pathways, reducing airway inflammation and edema. Additionally, these compounds may modulate cytokine release (e.g., TNF-α, IL-6) and scavenge reactive oxygen species, contributing to overall respiratory support.